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Background: Diabetic foot ulcers have a devastating impact on an individual’s health-related quality of life and
functional status. Additionally, diabetic foot ulcers impose a significant economic burden on our health care
systems as a result of complications such as infection, hospitalisation and amputation. The current gold standard
treatment for diabetic foot ulcers is total contact casting. However, the rate of ulcer recurrence is high, indicating
the need for more effective long-term treatment options. Therefore, the aim of this study was to systematically
identify, critique and evaluate all literature investigating the effectiveness of Achilles tendon lengthening,
gastrocnemius recession and selective plantar fascia release in healing and preventing diabetic foot ulcers.
Review: Searches were conducted in MEDLINE, CINAHL, AMED, EMBASE and The Cochrane Library from the earliest
available date to November 2014. Methodological quality of included studies was assessed using the Downs and
Black checklist. Data from randomised-controlled trials were analysed using random effects meta-analysis. For all
other studies, data were analysed descriptively.
Eleven studies (614 participants) were included in the review, with a median sample size of 29 participants. Meta-analysis
of two randomised-controlled trials found that there was no statistically significant difference between Achilles tendon
lengthening or gastrocnemius recession and total contact casting for time to healing of diabetic foot ulcers (mean
difference, MD, 8.22 days; 95 % CI, −18.99 to 35.43; P = 0.55; I2 = 34 %) and the rate of ulcers healed (risk ratio, RR, 1.06;
95 % CI, 0.94 to 1.20; P = 0.34; I2 = 41 %). The rate of ulcer recurrence was significantly lower following Achilles tendon
lengthening or gastrocnemius recession than total contact casting (RR, 0.45; 95 % CI, 0.28 to 0.72; P < 0.001; I2 = 0 %).
Conclusions: Achilles tendon lengthening and gastrocnemius recession appear to be effective surgical treatments for
healing diabetic foot ulcers. The rate of ulcer recurrence was lower following Achilles tendon lengthening or
gastrocnemius recession procedures compared to total contact casting treatment alone. Therefore, these surgical
procedures may provide viable treatment options for the management and prevention of diabetic foot ulcers. Further
rigorous randomised-controlled trials with longer follow-up are required to determine the long-term effectiveness and
safety of these procedures.
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Diabetic foot ulceration is a global public health problem.
Foot ulcers have a devastating impact on an individual’s
health-related quality of life and functional status. Further
complications such as infection, hospitalisation and ampu-
tation are common. An estimated 15 % of people with dia-
betes will develop an ulcer during their lifetime [1] and
approximately 85 % of all non-traumatic lower extremity
amputations in people with diabetes are preceded by a
foot ulcer [1, 2]. Consequently, foot ulcers impose a signifi-
cant economic burden on our health care systems [1, 3].
Sensory neuropathy and high plantar pressures have
been implicated in the development of diabetic foot
ulceration [3, 4]. The current gold standard treatment is
total contact casting (TCC), which is a conservative
treatment method shown to be effective in reducing
plantar pressures [5, 6] and healing neuropathic ulcers
in people with diabetes [7–13]. However, reported rates
of ulcer recurrence are high, ranging from 19 % to 81 %
[9, 10, 12–15]. These high recurrence rates may be ex-
plained by the temporary offloading effect provided by
TCC. It may also reflect the difficulty in preventing ulcer
recurrence in neuropathic feet through means of foot-
wear, insoles and appropriate foot care, and patient com-
pliance with these modalities [14]. Thus, a more effective
long-term treatment option for preventing the develop-
ment and recurrence of diabetic foot ulceration is needed.
Limited ankle joint dorsiflexion (i.e., equinus deform-
ity) is associated with elevated plantar pressures, which
subsequently increases the risk of plantar ulceration in
people with diabetes [16, 17]. There is a threefold risk of
equinus deformity in those with diabetes compared to
those without [16]. This is thought to be a result of non-
enzymatic glycosylation [4, 18, 19], which alters the
structure and function of collagen within connective tis-
sues, such as tendons and fascia, causing stiffness. Short-
ening of the Achilles tendon can result in plantarflexion
at the ankle and increased plantar forefoot pressures
during gait [17]. Achilles tendon lengthening (ATL) and
gastrocnemius recession (GR) procedures have been
found to increase ankle joint dorsiflexion [15, 20, 21]
and ATL has been found to reduce plantar forefoot
pressures [20]. Hence, these procedures may provide vi-
able options for the management of diabetic foot ulcers.
However, potential risks associated with these surgical
procedures must also be considered. One such risk is
over-lengthening of the tendon which can result in a cal-
caneal gait, chronic heel ulceration and tendon rupture.
With this in mind, selective plantar fascia release (SPFR)
has been proposed as an alternative procedure to ATL
for the management of diabetic foot ulcers [22].
To our knowledge, there has been no systematic re-
view and meta-analysis investigating the effectiveness of
these surgical procedures in the management of diabeticfoot ulcers. Therefore, the aim of this review was to sys-
tematically identify, critique and evaluate all literature
investigating the effectiveness of ATL, GR and SPFR in
healing and preventing diabetic foot ulcers. The primary
outcome measures were time to healing of the ulcer, rate
of ulcers healed, rate of ulcer recurrence, and rate of
transfer ulcers (i.e., a new ulcer). The secondary out-
come measures were complications and adverse events.Review
Methods
Registration
This systematic review was prospectively registered on
PROSPERO (Registration No. CRD42013006290).Search strategy
Searches were conducted from the earliest available date
to September 2013 in MEDLINE, CINAHL, AMED,
EMBASE and The Cochrane Library. The detailed
search strategy used for MEDLINE is available in Add-
itional file 1. The reference lists of included articles were
checked and citation tracking using Google Scholar was
performed to identify any further relevant citations.
Searches were repeated in November 2014 to ensure any
new citations were identified and assessed for eligibility
prior to submission.Selection criteria
The titles and abstracts of records identified in the
search were independently screened by two reviewers
(SMD and MRK) based on the inclusion and exclusion
criteria (Table 1). Full text was obtained for any articles
in which a decision to include or exclude the article
could not be made based on the information provided in
the title or abstract. Any disagreements were discussed
until a consensus was reached.
For relevant studies where the data were not separated
for participants with and without diabetes, or where par-
ticipants had undergone different surgical procedures,
the authors were contacted for their raw data. Studies in
which the raw data were obtained from responding
authors were subsequently included in the review.Data extraction
One author (SMD) extracted primary study data using a
customised data extraction form which included infor-
mation regarding study design, participant characteris-
tics, intervention details, outcomes of interest, outcome
results, complications and length of follow-up. Data ex-
traction was independently confirmed by the second au-
thor (MRK).
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Population Studies of participants
diagnosed with:
Studies in which the data
was not separated for
participants with and
without diabetesi. Type 1 or Type 2
Diabetes Mellitus
And
ii. Plantar forefoot or
midfoot ulceration
Intervention Studies of participants who





iii. Plantar fascia release
Outcomes Studies investigating:
i. Time to healing of the ulcer
And/ Or
ii. Rate of ulcers healed
And/ Or
iii. Rate of ulcer recurrence
And/ Or




Peer-reviewed publications Conference presentations
Case studies
Studies published in a
language other than English
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The methodological quality of included studies was
assessed using the Downs and Black (1998) checklist,
which has been shown to be valid and reliable [23]. It is
comprised of 27 items (10 relating to reporting, three
relating to external validity, seven relating to internal
validity – bias, six relating to internal validity – confound-
ing, and one relating to power) with a maximum achievable
score of 32. Scoring for item 27 relating to study power was
modified in this review for easier application and analysis
by the assessors. Studies in which a power analysis was per-
formed and were adequately powered were given a score of
five. Studies in which a power analysis was performed but
where sample sizes were borderline, or studies that were
able to determine a statistically significant difference despite
questionable sample sizes, were given a score of three.
Studies in which a power analysis was not performed and
were clearly underpowered were given a score of zero.
While modification altered the total achievable score for
this individual item (i.e., studies were not able to score a
one, two or four), all studies were rated using the same
scale and therefore comparability between the studies
was not affected. Quality assessment was independentlyperformed by two assessors (SMD and MRK). Any dis-
agreements were discussed until a consensus was reached.
Data analysis
All data from randomised-controlled trials (RCTs) were
analysed by meta-analysis with the inverse-variance
method. Time to healing of the ulcer was analysed by cal-
culating the mean difference (MD) and 95 % confidence
intervals (CIs) using a random effects model. Where data
were reported as a median and range, the mean and
standard deviation were estimated [24]. Rate of ulcers
healed and rate of ulcer recurrence were analysed by cal-
culating risk ratios (RRs) and 95 % CIs using a random ef-
fects model. A P-value of 0.05 was considered statistically
significant. Heterogeneity between the studies was deter-
mined using the I2 statistic [25]. Meta-analyses were con-
ducted using Review Manager (RevMan Version 5.3.
Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration, 2014).
For all other studies, data relating to time to healing of
the ulcer, rate of ulcers healed and rate of ulcer recur-
rence were analysed descriptively. Rate of transfer ulcers
and reported complications and adverse events that oc-
curred in the intervention groups were also analysed de-
scriptively and were calculated in terms of number of
participants. The rate of transfer ulcers included heel ul-
cers, however the rate of heel ulcers was also analysed
separately as a complication of the procedures.
Results
The results of the search process are shown in Fig. 1. A
total of 11 studies (614 participants) [15, 21, 22, 26–33]
were included in the review, with a median sample size of
29 participants. There were two RCTs [15, 21], one pro-
spective cohort study [28], three prospective case series
[22, 26, 30], two retrospective cohort studies [27, 33] and
three retrospective case series [29, 31, 32]. Characteristics
of included studies are presented in Table 2. A detailed
table of the extracted data (including individual study re-
sults and complications) is available in Additional file 2.
Quality assessment
The quality assessment scores of the 11 studies ranged
from nine to 27 with a mean and standard deviation of
17 ± 5. The results of quality assessment are shown in
Table 3. A table outlining the detailed scoring for each
of the 27 items is available in Additional file 3.
Ten studies [15, 21, 22, 27–33] scored eight or higher
for reporting, indicating the majority of included studies
provided sufficient information regarding study objec-
tives, methods and results. More than half of the studies
[15, 21, 22, 26, 28, 33] scored zero for external vali-
dity, demonstrating studies had suboptimal recruitment
methods or failed to adequately describe them. Eight
Fig. 1 Flow diagram of search process
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maximum 13) for internal validity, which assessed bias in
subject selection and measurement of outcomes. Six studies
[26, 28–31, 33] scored zero for power, indicating they
had insufficient power to detect a statistically significant
effect.
Time to healing of the ulcer
Two RCTs [15, 21] investigated the effectiveness of ATL or
GR (intervention group) versus TCC (control group) on
time to healing of diabetic foot ulcers. Participants in theintervention group of one study [21] had either ATL or
GR, which was determined based on dorsiflexion measure-
ment at the ankle joint with the knee straight and flexed. A
meta-analysis found that there was no statistically signifi-
cant difference in mean time to healing of diabetic foot ul-
cers between the intervention and control groups (MD,
8.22 days; 95 % CI, −18.99 to 35.43; P = 0.55; I2 = 34 %)
(Fig. 2). The mean time to healing reported in the inter-
vention groups was 57.5 days [15] and 75.5 days [21]. As
the results were not separated for the ATL and GR partici-
pants in the study by Allam (2006) [21], comparisons
Table 2 Characteristics of included studies
Study Number of participants / Number of ulcers Baseline age
(years)a





Intervention group Control group Forefoot Midfoot
Allam, 2006* [21] 15 14 55.0 ± 11.0 Not reported 20.0 ± 11.0 Median 42.0
(range 1 72)
●
Batista et al., 2011† [26] 52 N/A Mean = 66.4 Not reported >5 years
(100% participants)
N/A ●
Colen et al., 2013‡ [27] 138 / 145 149 / 179 58.5 ± 10.0 59 % Not reported Not rep ed ● ●
Dayer & Assal, 2009§ [28] 24 N/A 56.3 ± 12.4 42 % Not reported 15.9 ± 7 ●
Hamilton et al., 2005¶ [29] 7 N/A 51.3 ± 10.9 Not reported Not reported Not rep ed ●
Kim et al., 2012† [22] 60 / 64 N/A 54.1 ± 14.3 62 % >10 years
(70% participants)
5.5 ± 3. ●
Laborde, 2005† [30] 17 / 20 N/A 58.7 ± 12.3 53 % Not reported 12.9 ± 1 ●
Laborde, 2009¶ [31] 10 / 10 N/A 60.1 ± 15.1 60 % Not reported 16.2 ± 2 ●
La Fontaine et al.,
2008¶ [32]
28 N/A Median = 51.0
(range 24–72)
71 % Not reported Not rep ed ● ●

















Mueller et al., 2003* [15] 31 33 56.0 ± 10.0 77 % 18.4 ± 11.7 Not rep ed ●




Gastrocnemius recession Selective plantar
fascia release
Time to healing Rate of ulcers
healed
Rate of er recurrence Rate of transfer
ulcers
Allam, 2006* [21] ○ ○ ♦ ♦ ♦ Mean = 24.0
Batista et al., 2011† [26] ○ ♦ Mean = 24.0
Colen et al., 2013‡ [27] ○ ♦ ♦ 35.3 ± 11.0
Dayer & Assal, 2009§ [28] ○ ♦ ♦ ♦ ♦ 39.2 ± 12.2
Hamilton et al., 2005¶ [29] ○ ♦ ♦ ♦ ♦ 17.1 ± 7.3
Kim et al., 2012† [22] ○ ♦ ♦ Mean = 23.5
Laborde, 2005† [30] ○ ♦ ♦ ♦ 34.6 ± 19.3
Laborde, 2009¶ [31] ○ ♦ ♦ ♦ 35.2 ± 18.5
La Fontaine et al.,
2008 ¶[32]

































Table 2 Characteristics of included studies (Continued)




Gastrocnemius recession Selective plantar
fascia release
Time to healing Rate of ulcers
healed
Rate of ulcer recurrence Rate of transfer
ulcers




Mueller et al., 2003* [15] ○ ♦ ♦ ♦ 25.2 ± 8.4
aUnless shown otherwise, baseline age given as mean ± standard deviation
bUnless shown otherwise, duration of diabetes given as mean ± standard deviation
cUnless shown otherwise, duration of ulcer given as mean ± standard deviation



































Allam, 2006 [21] 9 0 4 2 3 18
Batista et al., 2011 [26] 5 0 2 2 0 9
Colen et al., 2013 [27] 9 2 5 2 3 21
Dayer et al., 2009 [28] 10 0 3 2 0 15
Hamilton et al., 2005 [29] 9 2 2 3 0 16
Kim et al., 2012 [22] 9 0 4 2 3 18
Laborde, 2005 [30] 9 2 2 2 0 15
Laborde, 2009 [31] 8 2 2 2 0 14
La Fontaine et al., 2008 [32] 9 3 4 3 5 24
Lin et al., 1996 [33] 8 0 3 1 0 12
Mueller et al., 2003 [15] 11 0 5 6 5 27
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studies [32, 33] found a mean time to healing following
ATL of 65.8 days and 39.3 days respectively.
Rate of ulcers healed
Two RCTs [15, 21] investigated the rate of ulcers healed fol-
lowing ATL or GR (intervention group) versus TCC (control
group). A meta-analysis found that there was no statistically
significant difference in the rate of ulcers healed between
the intervention and control groups (RR, 1.06; 95 % CI, 0.94
to 1.20; P= 0.34; I2= 41 %) (Fig. 3). The reported rate of ul-
cers healed in the intervention groups was 100 %. Three
other studies [31–33] found that the rate of ulcers healed
following ATL or GR was 88.9 %, 85.7 % and 93.3 % respect-
ively. One study [22] investigated the rate of ulcers healed
following SPFR, which was found to be 56.3 %.
Rate of ulcer recurrence
Two RCTs [15, 21] investigated the rate of ulcer recurrence
following ATL or GR (intervention group) versus TCC (con-
trol group). A meta-analysis found that the rate of ulcer re-
currence was significantly lower in the intervention group
than the control group (RR, 0.45; 95 % CI, 0.28 to 0.72;
P < 0.001; I2= 0 %) (Fig. 4). The rate of ulcer recurrenceFig. 2 Forest plot of studies investigating time (days) to healing of the ulce
total contact castingreported in the intervention groups was 38.5 % [15] and
20 % [21]. In the study by Allam (2006) [21], ulcer recur-
rence rates for the ATL and GR groups were 16.7 % and
22.2 % respectively. Four other studies [26, 31–33] found
that the rate of ulcer recurrence following ATL or GR was
7.7 %, 12.5 %, 41.7 % and 0 % respectively. One study [22]
investigated the rate of ulcer recurrence following SPFR,
which was found to be 0 %.
Rate of transfer ulcers
The rate of heel transfer ulcers reported in the intervention
groups of the two RCTs was 12.9 % [15] and 20 % [21]. The
results were not separated for the ATL and GR groups in
the study by Allam (2006) [21]. Two other studies [31, 32]
found that the rate of transfer ulcers (including heel ulcers)
following ATL or GR was 0 % and 21.4 % respectively.
Complications and adverse events
The complications and adverse events are listed in
Additional file 2. In the two RCTs [15, 21], a combined total
of seven participants (15.2 %) in the intervention groups
developed a heel ulcer following ATL or GR. Overall, three
deaths (6.5 %) were recorded in the intervention groups
during the follow-up period, however only one of theser for Achilles tendon lengthening or gastrocnemius recession versus
Fig. 3 Forest plot of studies investigating the rate of ulcers healed for Achilles tendon lengthening or gastrocnemius recession versus total
contact casting
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cause of death a myocardial infarction. Other reported com-
plications following surgery included wound haematoma
(6.5 %), calcaneal gait (4.3 %), and a ruptured Achilles ten-
don (4.3 %). One participant (2.2 %) developed an infection
requiring debridement and amputation. Mueller et al. (2003)
[15] also reported complications relating to TCC in both the
intervention and control groups which included abrasions
(12.9 % and 18.2 % respectively), falls (6.5 % and 0 % respect-
ively) and intolerance (0 % and 9.1 % respectively). In the
study by Allam (2006) [21], early complications from surgery
were reported separately for the ATL and GR groups, which
included wound haematoma (16.7 % and 22.2 % respect-
ively), calcaneal gait (16.7 % and 0 % respectively), and a
ruptured Achilles tendon (16.7 % and 11.1 % respectively).
Four other studies [26, 31–33] also reported complica-
tions following ATL or GR. Five heel ulcers (4.8 %) were
recorded across the intervention groups of these studies
during the follow-up period. There were two deaths
(1.9 %), however these were reported as complications of
the comorbidities of diabetes rather than the surgery
[31]. One participant (1.0 %) developed an infection re-
quiring partial foot amputation, and one participant
(1.0 %) had gangrene requiring an above knee amputa-
tion. The study investigating SPFR [22] reported no
complications associated with the procedure.
Discussion
Increased plantar pressures in conjunction with neur-
opathy have been implicated in the development ofFig. 4 Forest plot of studies investigating the rate of ulcer recurrence for A
contact castingplantar foot ulceration in people with diabetes. At
present, the gold standard treatment for diabetic foot
ulcers is TCC. However, ulcers often recur following ces-
sation of this treatment, which may be explained by the
temporary nature of offloading provided by TCC. Achilles
tendon lengthening and GR procedures increase the range
of dorsiflexion at the ankle joint, while SPFR increases the
range of motion at the metatarsophalangeal joints. In the-
ory, improved dorsiflexion range of motion at the ankle
and metatarsophalangeal joints decreases plantar forefoot
pressures and the risk of plantar foot ulceration.
This review found that ATL and GR appear to be effect-
ive surgical treatments for healing diabetic foot ulcers
when an equinus deformity is present. Interestingly, there
was no statistically significant difference between these
procedures and the current gold standard treatment of
TCC for time to healing of the ulcer and the rate of ulcers
healed. However, the rate of ulcer recurrence was found
to be lower in participants who had undergone ATL or
GR procedures compared to those treated with TCC
alone. One RCT [15] included in this review also found
that re-ulceration occurred significantly earlier in those
managed with TCC alone compared to those who under-
went ATL in conjunction with TCC (P = 0.03).
Conversely, surgery can expose patients to greater
complications and adverse events. Our review found that
the development of transfer ulcers, particularly under
the heel, were the most common complications follow-
ing ATL or GR procedures. Transfer ulcers may occur
due to pressure being transferred elsewhere under thechilles tendon lengthening or gastrocnemius recession versus total
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correction. As SPFR does not affect ankle joint range of
motion, it may reduce the risk of heel ulcers. However,
future RCTs are required to determine this. The rate of
other complications in the included studies was low,
which is in agreement with a previous study that found
there is low morbidity associated with gastrocnemius re-
cession [34]. At present, ATL appears to be the proced-
ure of choice as it is relatively quick and easy to perform
[35]. Further high-quality RCTs are needed to determine
which of these methods may be associated with fewer
complications and improved patient outcomes. Consider-
ation of where the limited joint range of motion is present
will also guide which procedure is most appropriate.
While the results of this review suggest ATL and GR
may provide viable treatment options for healing and
preventing diabetic foot ulcers, the long-term effective-
ness and safety of these procedures remains unknown.
There is also limited evidence regarding the precise
mechanisms by which these procedures heal and prevent
ulceration. Armstrong et al. (1999) [20] found that peak
plantar forefoot pressures were reduced and ankle joint
dorsiflexion was increased following ATL at eight weeks
follow-up. Similarly, Mueller et al. (2003) [15] found that
peak plantar forefoot pressures were reduced and ankle
joint dorsiflexion was increased post-operatively follow-
ing ATL. However, plantar pressures returned to base-
line values at seven months follow-up. Despite this, the
observed increase in ankle joint dorsiflexion remained
and re-ulceration rates were significantly lower in those
who had undergone ATL compared to those in the TCC
group. Allam (2006) [21] also recorded a significant im-
provement in ankle joint dorsiflexion post ATL or GR.
This decreased after two years follow-up though remained
within the normal range.
Orendurff et al. (2006) [36] found that despite a statisti-
cally significant relationship between equinus deformity of
the ankle and increased peak plantar forefoot pressures
during walking, the relationship was weak (R2 = 0.149).
While this may still be of clinical relevance, this result
suggests that other contributing factors may also play a role
(e.g., bony deformities, thickness of plantar tissues, modifi-
cation of gait) [36]. Orendurff et al. (2006) [36] discuss that
a prolonged period of increased pressure under the forefoot
during gait, as a result of equinus deformity, may play a role
in ulcer development and requires further investigation.
This is the first systematic review and meta-analysis to
investigate the effectiveness of ATL, GR and SPFR
in healing and preventing diabetic foot ulcers. The
strengths of this review include a rigorous search strat-
egy, studies were selected, reviewed and assessed system-
atically by two independent reviewers using standardised
methods, the relevance of the results to clinical practice
and research prioritisation were discussed, and finally,the manuscript was reported in accordance with the
PRISMA guidelines [37].
The main limitation of this review was that the majority
of studies were not RCTs and ranged in the level of qual-
ity. The results of studies (i.e., those that weren’t RCTs)
were reported descriptively as we believe that these data
add to the overall literature on this topic and are import-
ant from a clinical perspective. However, based on quality
assessment, the results of these studies should be inter-
preted with caution. The participants in some of the stud-
ies also had concurrent surgical procedures and therefore
we cannot be certain that the outcomes were a direct
result of the procedures investigated in this review. Ac-
cordingly, the findings of these studies were not reported
separately within the written section of the results. How-
ever, individual study results can be obtained from Table 2
(Characteristics of included studies) and Additional file 2
(Data extraction table). As there was only one study
investigating SPFR, results were unable to be pooled in a
meta-analysis. Furthermore, the study was not a RCT, and
therefore the findings should be interpreted with caution.
A further limitation was the exclusion of studies where
data were not separated for participants with and without
diabetes (i.e., where the raw data could not be obtained
from the authors), and studies printed in a language other
than English. As a result, this review may not have in-
cluded all available data possible for use in meta-analyses.
Conclusions
This review found that ATL and GR appear to be effect-
ive surgical treatments in healing diabetic foot ulcers
when an equinus deformity is present. Meta-analysis
found that there was no statistically significant difference
between these procedures and the current gold standard
treatment of TCC for time to healing of the ulcer and
the rate of ulcers healed. The rate of ulcer recurrence
was lower following ATL or GR procedures compared to
TCC treatment alone. Therefore, these surgical proce-
dures may provide viable treatment options for the
management and prevention of diabetic foot ulcers. Fur-
ther rigorous RCTs with longer follow-up are required
to determine the long-term effectiveness and safety of
these procedures.
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